VIDEO: Melanoma immune cell composition may predict benefit from combination immunotherapy
- Jeremy Visser
- Apr 22
- 1 min read
According to a recent study, the tumour immune cell environment may determine whether or not a melanoma patient will respond to combination immunotherapy.
Comments